Target announces a number of leadership changes that will further the companys efforts to drive U.S. traffic and sales, improve its Canadian operations, and advance its ongoing digital transformation.
Crocs names a new President who will assume the role of principal executive officer until the companys search for a permanent CEO is successfully concluded.
The new company, to be called Jacobs Douwe Egberts (JDE), is expected to hold market positions in more than two dozen countries with a strong emerging market presence.
Under the terms of the agreement, Bayer AG will acquire Mercks existing OTC business, including the global trademark and prescription rights for Claritin and Afrin.